Interní Med. 2000; 2(1)

Lamivudin - významný příspěvek v léčbě chronické hepatitidy

doc. MUDr. Zdeněk Fryšák CSc
III. interní klinika FN a LF UP Olomouc

B

Published: December 31, 2000  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fryšák Z. Lamivudin - významný příspěvek v léčbě chronické hepatitidy. Interní Med. 2000;2(1):.

Na příkladu dvou nemocných s pokročilým jaterním onemocněním typu chronické hepatitidy B s přechodem do jaterní cirhózy autor dokumentuje účinnost terapie lamivudinem, nukleosidovým analogem. Ten se jeví nejen jako rovnocenný partner interferonu-a, ale v řadě indikací se stane lékem volby.

Download citation




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.